Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
PALATINE, Ill., March 01, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced an amendment to its License, Development and Commercialization Agreement…